Literature DB >> 29174085

Resistance to first-line ART and a role for dolutegravir.

Richard Kaplan1, Robin Wood2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29174085     DOI： 10.1016/S2352-3018(17)30207-2

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  2 in total

1.  CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor.

Authors:  Junjie Zhu; Pengcheng Wang; Feng Li; Jie Lu; Amina I Shehu; Wen Xie; Deborah McMahon; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2018-10-17       Impact factor: 5.858

Review 2.  Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.

Authors:  Bluma G Brenner; Ruxandra-Ilinca Ibanescu; Isabelle Hardy; Michel Roger
Journal:  Viruses       Date:  2017-12-28       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.